-
公开(公告)号:US20110294792A1
公开(公告)日:2011-12-01
申请号:US13206057
申请日:2011-08-09
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61K31/551 , A61P19/08 , C07D487/04
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
-
公开(公告)号:US20110207721A1
公开(公告)日:2011-08-25
申请号:US13100618
申请日:2011-05-04
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61K31/5517 , C07D487/04 , A61P3/10 , A61P25/28
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式I的激酶抑制剂。
-
公开(公告)号:US08058425B2
公开(公告)日:2011-11-15
申请号:US13100618
申请日:2011-05-04
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: A61P25/08 , A61K31/55 , C07D487/06
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式的激酶抑制剂。
-
公开(公告)号:US20090105229A1
公开(公告)日:2009-04-23
申请号:US12333775
申请日:2008-12-12
申请人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel
发明人: Thomas Albert Engler , Timothy Paul Burkholder , Joshua Ryan Clayton , Clive Gideon Diefenbacher , Kelly Wayne Furness , James Robert Henry , Yihong Li , Sushant Malhotra , Angela Lynn Marquart , Johnathan Alexander McLean , David Mendel , Jon Kevin Reel
IPC分类号: A61K31/5517 , C07D487/16
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式I的激酶抑制剂。
-
5.
公开(公告)号:US07405305B2
公开(公告)日:2008-07-29
申请号:US10506029
申请日:2003-03-05
申请人: Pamela Ann Albaugh , Jochen Ammenn , Timothy Paul Burkholder , Joshua Ryan Clayton , Scott Eugene Conner , Brian Eugene Cunningham , Thomas Albert Engler , Kelly Wayne Furness , James Robert Henry , Sushant Malhotra , Mark Joseph Tebbe , Guoxin Zhu , YiHong Li , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
发明人: Pamela Ann Albaugh , Jochen Ammenn , Timothy Paul Burkholder , Joshua Ryan Clayton , Scott Eugene Conner , Brian Eugene Cunningham , Thomas Albert Engler , Kelly Wayne Furness , James Robert Henry , Sushant Malhotra , Mark Joseph Tebbe , Guoxin Zhu , YiHong Li , Brian Raymond Berridge , Charles Edward Ruegg , John Morris Sullivan
IPC分类号: C07D209/12 , C07D207/24 , C07D211/06
CPC分类号: C07D451/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D471/04 , C07D491/04
摘要: The present invention provides kinase inhibitors of Formula (I)
摘要翻译: 本发明提供式(I)的激酶抑制剂,
-
公开(公告)号:US07666879B2
公开(公告)日:2010-02-23
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
IPC分类号: A01N43/42 , A61K31/44 , C07D471/02 , C07D491/02 , C07D498/02 , C07D513/02 , C07D515/02 , C07D401/00
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
公开(公告)号:US20090227622A1
公开(公告)日:2009-09-10
申请号:US11816416
申请日:2006-02-23
申请人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
发明人: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander Mclean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Yip , Boyu Zhong
IPC分类号: A61K31/437 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
摘要翻译: 本发明提供了下式所示的VEGF-R2抑制剂的化合物:(I)和使用这些化合物的方法。
-
公开(公告)号:US08022065B2
公开(公告)日:2011-09-20
申请号:US12333775
申请日:2008-12-12
IPC分类号: A61P25/28 , A61K31/55 , C07D487/06
CPC分类号: C07D471/06 , C07D487/06
摘要: The present invention provides kinase inhibitors of Formula I.
摘要翻译: 本发明提供式I的激酶抑制剂。
-
9.Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar 审中-公开
标题翻译: 杂环化合物作为过氧化物酶体增殖物激活受体的调节剂,可用于治疗和/或预防由Ppar调节的疾病公开(公告)号:US20080207685A1
公开(公告)日:2008-08-28
申请号:US10577828
申请日:2004-11-16
IPC分类号: A61K31/4709 , C07D217/24 , A61P3/10 , A61P9/10 , A61P3/04
CPC分类号: C07D413/12 , C07D217/06 , C07D413/14 , C07D417/12 , C07D417/14
摘要: The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,溶剂合物,水合物或立体异构体,其可用于治疗或预防由过氧化物酶体增殖物激活受体(PPAR)介导的病症,例如综合征X, II型糖尿病,高血糖症,高脂血症,肥胖症,凝血病,高血压,动脉硬化以及与综合症X和心血管疾病相关的其它疾病。
-
公开(公告)号:US06984661B2
公开(公告)日:2006-01-10
申请号:US10500489
申请日:2003-01-21
申请人: James Robert Henry , YiHong Li
发明人: James Robert Henry , YiHong Li
IPC分类号: A61K31/36 , A61K31/195 , C07D317/44 , C07C323/63 , C07C275/28
CPC分类号: C07C275/36 , C07C275/10 , C07C275/24 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/38 , C07C2601/14 , C07C2602/08 , C07D317/66
摘要: The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each independently selected from the group consisting of hydrogen, C1-C8 alkyl substituted C1-C8 alkyl, aryl-C0-4-alkyl, substituted aryl-C0-4-alkyl, heteroaryl-C0-4-alkyl, substituted heteroaryl-C0-4-alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl, and substituted C3-C6 cycloalkylaryl-C0-2-alkyl; (b) X is an optionally substituted C1-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S; (c) Y is C, O, S, NH or a single bond; and (d) E is selected from the group consisting of hydrogen, C(R3)(R4)A, A, (CH2)n COOR19 and substituted (CH2)n COOR19.
摘要翻译: 本发明涉及结构式(I)的化合物及其药学上可接受的盐,溶剂合物和水合物:式I(a)R 1,R 2和R 6各自独立地选自氢,C 1 -C 6烷基, 1个C 1 -C 8烷基取代的C 1 -C 8烷基,芳基-C 0-4 SUB 烷基,取代的芳基-C 0-4 - - 烷基,杂芳基-C 0-4 - - 烷基,取代的杂芳基-C 0-4 - C 1 -C 6烷基,C 3 -C 6环烷基芳基-C 0-2-2 - 烷基和取代的C 3 - -C 6环烷基芳基-C 0-2-2 - 烷基; (b)X是任选取代的C 1 -C 5亚烷基连接体,其中连接体的一个碳原子可被O,NH或S取代; (c)Y是C,O,S,NH或单键; 和(d)E选自氢,C(R 3)(R 4)A,A,(CH 2 CH 2)n COOR 19和取代的(CH 3) 其中,COOR19为低级烷基。
-
-
-
-
-
-
-
-
-